Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Rhea-AI Summary

Pfizer Inc. (NYSE: PFE) will host a webcast on February 16, 2023, at 10:00 a.m. EST, featuring Andy Schmeltz and Navin Katyal discussing the company's mRNA portfolio at the SVB Securities Global Biopharma Conference. Interested parties can access the live discussion via Pfizer's investor website, www.pfizer.com/investors. A transcript and replay of the webcast will be available within 24 hours, accessible for at least 90 days. Pfizer focuses on innovative therapies and vaccines to enhance patient lives globally, highlighting its commitment to health care access.

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Andy Schmeltz, SVP Commercial Strategy & Innovation, and Navin Katyal, U.S. Commercial & Global Business Lead for mRNA Portfolio at the SVB Securities Global Biopharma Conference on Thursday, February 16, 2023 at 10:00 a.m. Eastern Standard Time.

To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.

The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.

About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans, strategy and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, pricing and reimbursement, potential market dynamics and size, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities; and our ability to successfully capitalize on growth opportunities and prospects; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Category: Finance

View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005016/en/

Media:

PfizerMediaRelations@Pfizer.com

+1 (212) 733-1226

Investors:

IR@Pfizer.com

+1 (212) 733-4848

Source: Pfizer Inc.

FAQ

What date is Pfizer's webcast at the SVB Securities Global Biopharma Conference?

Pfizer's webcast at the SVB Securities Global Biopharma Conference is scheduled for February 16, 2023.

What time will the Pfizer webcast start on February 16, 2023?

The Pfizer webcast will start at 10:00 a.m. Eastern Standard Time on February 16, 2023.

Who will be speaking at Pfizer's webcast on February 16, 2023?

Andy Schmeltz and Navin Katyal will be speaking at Pfizer's webcast on February 16, 2023.

Where can I access Pfizer's February 16, 2023, webcast?

You can access Pfizer's February 16, 2023, webcast at www.pfizer.com/investors.

Will a replay of Pfizer's February 16, 2023, webcast be available?

Yes, a replay and transcript of Pfizer's February 16, 2023, webcast will be available within 24 hours and accessible for at least 90 days.